MEIS1 and leukemia: If the activation of this cell‐fate program is blunted by genetic or epigenetic mechanisms, leukemia cells may become resistant to the Menin inhibitor despite its retained ability to silence HOXA/MEIS1 gene expression programs.107, 108, 109